Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia.
Hurkmans, EGE
Klumpers, MJ
Dello Russo, C
De Witte, W
Guchelaar, H-J
Gelderblom, H
Cleton-Jansen, A-M
Vermeulen, SH
Kaal, S
van der Graaf, WTA
Flucke, U
Gidding, CEM
Schreuder, HWB
de Bont, ESJM
Caron, HN
Gattuso, G
Schiavello, E
Terenziani, M
Massimino, M
McCowage, G
Nagabushan, S
Limaye, A
Rose, V
Catchpoole, D
Jorgensen, AL
Barton, C
Delaney, L
Hawcutt, DB
Pirmohamed, M
Pizer, B
Coenen, MJH
Te Loo, DMWM
- Publisher:
- FRONTIERS MEDIA SA
- Publication Type:
- Journal Article
- Citation:
- Front Pharmacol, 2022, 13, pp. 980309
- Issue Date:
- 2022
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Hurkmans, EGE | |
dc.contributor.author | Klumpers, MJ | |
dc.contributor.author | Dello Russo, C | |
dc.contributor.author | De Witte, W | |
dc.contributor.author | Guchelaar, H-J | |
dc.contributor.author | Gelderblom, H | |
dc.contributor.author | Cleton-Jansen, A-M | |
dc.contributor.author | Vermeulen, SH | |
dc.contributor.author | Kaal, S | |
dc.contributor.author | van der Graaf, WTA | |
dc.contributor.author | Flucke, U | |
dc.contributor.author | Gidding, CEM | |
dc.contributor.author | Schreuder, HWB | |
dc.contributor.author | de Bont, ESJM | |
dc.contributor.author | Caron, HN | |
dc.contributor.author | Gattuso, G | |
dc.contributor.author | Schiavello, E | |
dc.contributor.author | Terenziani, M | |
dc.contributor.author | Massimino, M | |
dc.contributor.author | McCowage, G | |
dc.contributor.author | Nagabushan, S | |
dc.contributor.author | Limaye, A | |
dc.contributor.author | Rose, V | |
dc.contributor.author |
Catchpoole, D https://orcid.org/0000-0001-5836-1413 |
|
dc.contributor.author | Jorgensen, AL | |
dc.contributor.author | Barton, C | |
dc.contributor.author | Delaney, L | |
dc.contributor.author | Hawcutt, DB | |
dc.contributor.author | Pirmohamed, M | |
dc.contributor.author | Pizer, B | |
dc.contributor.author | Coenen, MJH | |
dc.contributor.author | Te Loo, DMWM | |
dc.date.accessioned | 2024-03-14T04:31:43Z | |
dc.date.available | 2022-12-14 | |
dc.date.available | 2024-03-14T04:31:43Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Front Pharmacol, 2022, 13, pp. 980309 | |
dc.identifier.issn | 1663-9812 | |
dc.identifier.issn | 1663-9812 | |
dc.identifier.uri | http://hdl.handle.net/10453/176704 | |
dc.description.abstract | Hearing loss (ototoxicity) is a major adverse effect of cisplatin and carboplatin chemotherapy. The aim of this study is to identify novel genetic variants that play a role in platinum-induced ototoxicity. Therefore, a genome-wide association study was performed in the Genetics of Childhood Cancer Treatment (GO-CAT) cohort (n = 261) and the United Kingdom Molecular Genetics of Adverse Drug Reactions in Children Study (United Kingdom MAGIC) cohort (n = 248). Results of both cohorts were combined in a meta-analysis. In primary analysis, patients with SIOP Boston Ototoxicity Scale grade ≥1 were considered cases, and patients with grade 0 were controls. Variants with a p-value <10-5 were replicated in previously published data by the PanCareLIFE cohort (n = 390). No genome-wide significant associations were found, but variants in TSPAN5, RBBP4P5, AC010090.1 and RNU6-38P were suggestively associated with platinum-induced ototoxicity. The lowest p-value was found for rs7671702 in TSPAN5 (odds ratio 2.0 (95% confidence interval 1.5-2.7), p-value 5.0 × 10-7). None of the associations were significant in the replication cohort, although the effect directions were consistent among all cohorts. Validation and functional understanding of these genetic variants could lead to more insights in the development of platinum-induced ototoxicity. | |
dc.format | Electronic-eCollection | |
dc.language | eng | |
dc.publisher | FRONTIERS MEDIA SA | |
dc.relation | University of Technology SydneyUTSCG09 | |
dc.relation.ispartof | Front Pharmacol | |
dc.relation.isbasedon | 10.3389/fphar.2022.980309 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1115 Pharmacology and Pharmaceutical Sciences | |
dc.subject.classification | 3214 Pharmacology and pharmaceutical sciences | |
dc.title | Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia. | |
dc.type | Journal Article | |
utslib.citation.volume | 13 | |
utslib.location.activity | Switzerland | |
utslib.for | 1115 Pharmacology and Pharmaceutical Sciences | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology/School of Computer Science | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2024-03-14T04:31:42Z | |
pubs.publication-status | Published online | |
pubs.volume | 13 |
Abstract:
Hearing loss (ototoxicity) is a major adverse effect of cisplatin and carboplatin chemotherapy. The aim of this study is to identify novel genetic variants that play a role in platinum-induced ototoxicity. Therefore, a genome-wide association study was performed in the Genetics of Childhood Cancer Treatment (GO-CAT) cohort (n = 261) and the United Kingdom Molecular Genetics of Adverse Drug Reactions in Children Study (United Kingdom MAGIC) cohort (n = 248). Results of both cohorts were combined in a meta-analysis. In primary analysis, patients with SIOP Boston Ototoxicity Scale grade ≥1 were considered cases, and patients with grade 0 were controls. Variants with a p-value <10-5 were replicated in previously published data by the PanCareLIFE cohort (n = 390). No genome-wide significant associations were found, but variants in TSPAN5, RBBP4P5, AC010090.1 and RNU6-38P were suggestively associated with platinum-induced ototoxicity. The lowest p-value was found for rs7671702 in TSPAN5 (odds ratio 2.0 (95% confidence interval 1.5-2.7), p-value 5.0 × 10-7). None of the associations were significant in the replication cohort, although the effect directions were consistent among all cohorts. Validation and functional understanding of these genetic variants could lead to more insights in the development of platinum-induced ototoxicity.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph